Introduction
============

Post-operative infections have always been a feature of human life. Sepsis in modern surgery continues to be a significant problem for healthcare practitioners across the globe. Patients that are undergoing surgery or surgical procedures are at risk of acquiring infections at the site of incision as a result of the same surgical procedure. Surgical site infections (SSIs) are real risks associated with any surgical procedure and represent a significant burden contributing to morbidity and mortality, and increased cost to health services around the world ([@R1]).

SSI remains one of the critically serious problems in post-operative complications, constituting approximately 20% of all of health care-associated infections ([@R2]).

Although data on SSI in Kenya is scant, reports indicate that the situation is not that good. Reports from studies in Nigeria, Ethiopia, Sudan, Tanzania and some of the Kenyan hospitals are in harmony in terms of indicating that the situation warrants more attention ([@R3]--[@R8]).

Although surgical site infection is a relatively serious problem in our health institution, there are scanty published reports on the bacterial pathogens that are involved in SSIs in our local hospitals. The sporadic reports from the public sector hospitals are mainly from the microbiology laboratory records which may not show the complete clinical picture. Paucity of published data on risk factors for SSIs has impacted negatively on management of patients particularly in the resource strained setup. Data from this study could be used to benchmark for a large scale study that could be useful for policy makers to make informed decisions on issues of infection control pertaining to surgical wound sepsis.

The objective of this study was to determine the incidence of SSI, the bacteria isolated, their antimicrobial susceptibility patterns and the risk factors associated with surgical site infections (SSIs) among patients undergoing surgery at the Aga Khan University Hospital, Nairobi (AKUHN).

Materials and Methods
=====================

**Study Population:** Two hundred and sixty-eight (268) successive adult patients who were referred for surgery to the Aga Khan University Hospital, Nairobi between March 2008 and May 2009 and who had not undergone any surgical procedure in the previous one month were recruited into this study. This study excluded patients who were referred for surgery out of disease complications that were being managed and those on multiple antimicrobial exposures due to chronic care prior to the surgical procedure. All diagnostic surgical procedures were also excluded.

Pre-operative, intra-operative, post-operative and management related factors were recorded in detail on a structured questionnaire. Antibiotic prophylaxis was administered according to the institutional policy. The surgical sites were examined on the 2^nd^ post-operative day and then daily for pain, redness, warmth, and swelling and purulent drainage at the incision site. SSIs were diagnosed and defined by the surgeon according to the CDC definition ([@R10]). All patients\' charts, including laboratory reports were reviewed six times a week. Post-discharge examination of the surgical site was performed for all patients in the outpatient clinic for any evidence of SSIs. All patients were reviewed at follow-up clinics after seven days after discharge and other subsequent follow-ups were carried out at the consulting surgical clinics, breast clinic and casualty dressing clinic for the purpose of SSI surveillance. The follow-up process involved four consultant surgeons assisted by two resident surgeons and a team of infection control nurses. The surveillance was extended for up to 30 days after surgery.

Immediately on admission to the hospital, surveillance cultures were performed by swabbing the anterior nares, axilla, groin and perianal regions. Pus swabs were collected from infected surgical sites suspected of SSI and transported to the laboratory in Stuart\'s transport medium. Culture was done using standard bacteriological procedures. Bacterial identification was done by colony morphology analysis, Gram stain, routine biochemical tests and analytic profile indexing (bioMerieux, Inc., Hazelwood, MO). Susceptibility testing was done using the disk diffusion technique according to CLSI 2009 guidelines ([@R11]).

Standard operating procedures for sample collection, transport, culture and susceptibility testing for isolated organisms were followed to ensure procedural quality. *Escherichia coli* ATCC 25922, *Pseudomonas aeruginosa* ATCC 27853, *Staphylococcus aureus* ATCC 25923 and *Enterococcus faecalis* ATCC 29212 were used as control organisms. The microbiology laboratory at the Aga Khan University Hospital is a participant in UKNEQAS program in addition to being an internationally accredited laboratory (ISO 15189-2007).

Data were analyzed using SPSS version 17.0. Descriptive statistics was used to show simple frequencies and means. The chi-square test was used to determine the relationship between the dependent and the independent variables.

Institutional approval was obtained and the study was conducted according to the ethical guidelines of the declaration of Helsinki as revised in 2000 ([@R9]). All subjects provided written informed consent before entering the study. No one was recruited solely for the purpose of the study; results obtained were used in the improved management of the patients.

Results
=======

Two hundred and sixty-eight respondents were enrolled, 262 were followed through one month, and 6 were lost during follow-up. The respondents had a mean age of 38yrs; median age of 37 years and modal age of 45 years. More SSI cases were noted in adult patients (above 30 years) than younger patients below (30 years). A total of 189 females and 79 males were recruited in the study. Out of these, 24 (13.6%) of the female and 15(18%) of males patients developed SSI, although there was no statistically significant correlation between sex and SSI ([Table 1](#T1){ref-type="table"}).

###### 

Incidence rates of surgical site infection

  -------------------------------------------------------------------------------------------------------------------------
                                                                           Frequency     Incidence %   *p ≤ 0.05*   
  --------------------- --------------- ---------------------------------- ------------- ------------- ------------ -------
  **Overall**                           All infections after surgery       39(268)       14.60                      

                                        True SSI                           12(171)       7.00                       

  **Wound class**       **Class I**     Clean wound surgery                5(91)         5.50          0.506        

                        **Class II**    Clean contaminated wound surgery   7(80)         8.80          0.613        

                        **Class III**   Contaminated wound surgery         6(30)         20.00         0.09         

                        **Class IV**    Dirty wound surgery                20(67)        29.90         0.003        

  **Sex**                               Male                                             15(79)        18.90        0.082

                                        Female                                           24(189)       12.70        0.075

  **Operation Sites**                   Abdominal                                        10 (39)       25.64        0.093

                                        Neck                                             2 (38)        5.26         1.348

                                        Thorax                                           7 (39)        17.95        0.276

                                        Head                                             0(40)         0.00         \-

                                        Perineum                                         10(39)        25.64        0.093

                                        Upper Limbs                                      3 (39)        7.69         0.308

                                        Lower Limbs                                      7 (39)        17.95        0.543

  **BMI**                               ≤18.4                                            5(74)         6.76         0.073

                                        18.5--24.9                                       14(158)       8.86         0.098

                                        ≥25                                              20(36)        55.56        0.156

  **Preoperative**\                     Less than a day\                   4(23)\        17.39\        0.135\       
  **operative stay**                    1 day                              14(178)       7.87          0.106        

                                        2 days                                           5(15)         33.33        0.002

                                        3 days                                           3(12)         0.25         0.05

                                        4 days                                           2(2)          100.00       0.04

                                        5 days                                           3(3)          100.00       0.048

                                        7 days                                           2(4)          50.00        0.037

                                        \> 7 days                                        6(30)         20.00        0.024

  **ASA Grade**                                                            ASA Grade 1   27(197)       13.71        0.079

  **scores**                                                               ASA Grade 2   9(46)         19.56        0.084

                                                                           ASA Grade 3   3(25)         12.00        0.068

  **Intraoperative**                    No                                               25(190)       13.16        0.459

  **Prophylaxis**                       Yes                                              14 (78)       17.95        0.067
  -------------------------------------------------------------------------------------------------------------------------

**\*Key**

**SSI occurence (number of surgery in the category)**

**True SSI Rate = (SSI occurrence in Clean and clean contaminated/Total Clean and Clean contaminated Surgical procedure X 100)**

[Table 2](#T2){ref-type="table"} shows the frequencies of bacterial isolates from three stages of samples: Preoperative (Nasal, Axilla, Groin and Perianal), Intra-operative and Postoperative. Coagulase negative staphylococci showed high frequency in preoperative samples, *E. coli* in intra-operative and *S. aureus* in postoperative samples. Thirty-nine (39) cases of SSI were detected, 29 of the cases were culture positive, and 3 of the cases had multiple organisms (*S. aureus* with Coagulase negative *staphylococci; S. aureus* with *E. coli; Klebsiella spp* with *E. coli*). Repeat samples were excluded from the analysis. In 3 cases of SSI, *S. aureus* isolates with the same antibiogram were isolated from both nasal swab and pus swab, indicating a possible case of nasal carriage resulting in endogenous infection. Also, in one case of SSI, a *P. aeruginosa* isolate with the same antibiogram was isolated from the groin swab and surgical site pus swab. The preoperative cultures were included to show the relationship between bacteria isolated from the SSI and bacterial carriage by the respondents.

###### 

Bacteria isolated from the study subjects

                          Preoperative culture   Intraoperative   Postoperative                    
  ----------------------- ---------------------- ---------------- --------------- -------- ------- -----------
  Coagulase negative                                                                               
  *Staphylococcus*        94                     62               20              0        1       6(15.4%)
  *E. coli*               0                      0                8               58       2       5(12.8%)
  *S. aureus*             34                     27               0               0        1       12(30.8%)
  *Klebsiella spp*        1                      0                2               10       0       5(12.8%)
  *Kluyvera spp*          0                      0                5               8        0       5(12.8%)
  *Citrobacter frendii*   0                      3                2               0        0       0 (0)
  *Enterococcus spp.*     0                      0                8               5        0       0 (0)
  *P. aeruginosa*         0                      0                1               0        0       4 (10.3%)
  *Proteus spp.*          0                      0                0               4        0       0 (0)
  *Acinetobacter spp.*    0                      0                0               1        0       0 (0)
  *E. cloacae*            0                      0                0               0        0       1(2.6%)
  *Serratia marscence*    0                      0                0               0        0       1 (2.6%)
  **Total**               **129**                **92**           **46**          **86**   **4**   **39**

[Table 3](#T3){ref-type="table"} shows the resistance patterns of S. aureus and CN staphylococcus on selected antibiotics as outlined by AKUH (N) protocols for first line testing for gram positive.

###### 

Antibiotic susceptibility pattern for S. aureus and CN staphylococcus isolated from SSI

                    Frequency of Resistance   
  ----------------- ------------------------- ------------
  Ampicillin        **6 (60%)**               **4(80%)**
  Doxycycline       **4(40%)**                **3(60%)**
  Azithromycin      **3(30%**                 **3(60%)**
  Augmentin         **1(10%)**                **2(40%**
  Cefuroxime        **1(10%)**                **3(60%)**
  Ciprofloxacin     **5(50%)**                **1(20%)**
  Chloramphenicol   **2(20%**                 **2(40%**
  Oxacillin         **1(10%)**                **0**
  Netilmicin        **0**                     **0**
  Vancomycin        **0**                     **0**

[Table 4](#T4){ref-type="table"} shows the resistance patterns of gram negative bacteria on selected antibiotics as outlined by AKUH(N) protocols for first and second line testing for gram negative (*P.aeruginosa* was tested on second line antibiotics while the rest were tested on first line for gram negative bacteria).

###### 

Antibiotic susceptibility pattern for gram negative bacteria isolated from SSI

                      Frequency of Resistance                                             
  ------------------- ------------------------- ---------------- ------------------------ ----------------------
  Antibiotics         *Kluyvera spp.(n=4)*      *E. coli(n=4)*   *Klebsiella spp.(n=3)*   *P. aeruginosa(n=4)*
  Cotrimoxazole       **0(0%)**                 **3(75%)**       **2(67%)**               \-
  Doxycycline         **3(75%)**                **3(75%)**       **1(33%)**               \-
  Augmentin           **2(50%)**                **3(75%)**       **2(67%)**               \-
  Cefotaxime          **2(50%)**                **1(25%)**       **2(67%)**               \-
  Chloramphenicol     **1(25%)**                **2(50%)**       **1(33%)**               \-
  Cefuroxime          **1(25%)**                **2(50%)**       **0(0%)**                \-
  Ciprofloxacin       **1(25%)**                **2(50%)**       **0(0%)**                **3(75%)**
  Gentamicin          **1(25%)**                **2(50%)**       **2(67%)**               **2(50%)**
  Tazo-piperacillin   \-                        \-               \-                       **3(75%)**
  Cefepime            \-                        \-               \-                       **2(50%)**
  Ceftazidime         \-                        \-               \-                       **2(50%)**
  Imipenem            \-                        \-               \-                       **2(50%)**
  Piperacillin        \-                        \-               \-                       **2(50%)**
  Ceftriaxone         \-                        \-               \-                       **1(25%)**

Key

*E. cloacae* and *Serratia marcescens* susceptibility pattern not included because only one ([@R1]) of each was isolated in SSI

\- Not tested

Discussion
==========

It was noted that the true incidence rate of SSI at the hospital was 7.0%. The findings of this study were at variance with the findings of a study by Brown *et al.*, ([@R12]) in Russia which reported a 9.5% incidence and Mitchell *et al.* ([@R13]) in Australia that reported an incidence rate of 10%. A study in Bolivia by Soleto *et al.* ([@R14]) reported an incidence rate of 12% whereas in Sudan, Abdalla *et al.* ([@R3]) reported a 13.8% SSI incidence rate; Ericksen *et al.*, Tanzania reported SSI rate of 19.4% in 2003 ([@R15]).

Although the findings of the study are at variance with most SSI studies reviewed, the relatively low incidence rates observed were comparable with study findings by Petrosillo *et al.* ([@R16]) in Italy who reported the SSI incidence rate of 5.2% in 2008, and findings from the study by Fiorio *et al.*, in 2006 that reported incidence of SSI of 5.2% in 100 operations ([@R17]). Variable occurrence rates were observed in different groups in this study. Incidence rate among females was found to be lower than among males. It was, however, difficult to establish the reason for the variation, although this observation was also reported from a study by Brown *et al.*, ([@R12]) in Russia. It was proven that the SSI rate was higher in dirty wounds class than in any other class. These findings confirm that the dirtier the wound is, the higher the chances of infection and are in agreement with the findings from other studies ([@R18]--[@R20]).

This study found out that the pathogens involved in SSI at the AKUHN included *S. aureus* (30.8%), *Coagulase negative Staphylococcus* (15.4%), *Pseudomonas aeruginosa* (10.4%), *Kluyvera spp.* (12.8%), *E. coli* (12.8%), *Klebsiella species* (12.8%), *Serratia marcescens* (2.6 %) and *Enterobacter cloacae* (2.6%). A report (Internal audit Report 2007) from Aga Khan University Hospital, Nairobi, Microbiology section, agrees with the findings of this study in that the most prevalent pathogen isolated from the pus swabs taken from patients with postoperative history is *Staphylococcus aureus*.

The findings of other surveillance studies are in agreement with the findings of this study in terms of the distribution of the organism isolated from the surgical site. Ericksen *et al*, in Tanzania reported a prevalence of 54.5% ([@R15]), Tourmousoglou *et al* in 2008 in Greece reported *S.aureus* as the most common bacteria from infected surgical site among other pathogens recovered in that study ([@R21]); similar findings were reported in Sudan by Abdalla *et al.*, in 1998 ([@R3]).

Contrary to the findings of this study, a study done in Nigeria by Oguntibeju and Nwobu 2004 ([@R22]) reported *Pseudomonas aeruginosa* as the most prevalent pathogen recovered from SSI among microorganisms. The study revealed that *Pseudomonas aeruginosa* was the most prevalent pathogen causing sepsis post-surgery followed closely by *Staphylococcus aureus*. A study by Kohli *et al, in* 2010 at the Aga Khan University Hospital that also revealed *S. aureus* as the most prevalent organism also confirms the *S. aureus* high prevalence ([@R23]). Additionally, findings showed that infection occurred in all individuals irrespective of medical underlying condition. Intraoperative prophylaxis did not alter disease outcome as shown by the results. Varied SSI occurrence was noted on anatomical sites while abdominal and perineum surgery had the highest frequency among other anatomical sites.

Although the numbers of microorganisms isolated in the study were low, the sensitivity pattern revealed that the prevalence of MRSA (one ([@R1]) isolate) is low among the *staphylococcus* species isolated from SSI. Recent studies done at the Aga Khan University Hospital further revealed the absence of nasal carriage among the hospital care-givers ([@R24]). The MRSA prevalence in this study is comparatively lower compared with the study findings by Brown *et al.*, ([@R12]) in Russia and Thu *et al.*, (2006) in Vietnam ([@R25]).

This study found out that wound class IV and preoperative stay ≥2 days were the risk factors associated with SSI at the hospital. Different studies in the world have associated SSIs to different risk factors in varied settings. Fehr *et al.*, ([@R4]) at Ifakara Hospital, Tanzania, reported ASA score of 2 or higher, duration of surgery greater than 75^th^ percentile of the duration for the relevant type of surgical procedure, type of intervention, and wound class. Brown *et al.*, ([@R12]), in Russia, in his study reported that emergency operation, male sex, ASA classification greater than 2, wound class greater than 2 and prolonged operation duration were significant predictors of SSI. Soleto *et al.*, ([@R14]), in Bolivia, reported that ASA scores, wound class, procedure duration and presence of drains were significantly associated with SSI. The above findings from different studies and settings identified wound class as a common risk factor associated with SSI which is similar to the findings of this study. Prolonged preoperative hospital stay is frequently suggested as a patient characteristic associated with increased SSI risk. However, length of preoperative stay is likely a surrogate factor for severity of illness and comorbid conditions requiring inpatient workup and/or therapy before operation ([@R26]).

Pus swabs are not ideal specimens for study of SSI according to CDC definitions; however, it was clinically not practical to obtain ideal specimens from the study population due to patient acceptability and constrains of resources. Although the SSI was defined according to CDC protocol, the SSIs were not stratified according to superficial, deep and organ space. All precautions were taken to avoid skin contaminants. The lack of anaerobic culture system was additional limitation.

In conclusion, the SSI incidence rate (7.0%) observed in this study were relatively lower than the ones documented in other studies in Kenya. *S. aureus* is the most prevalent pathogen associated with SSI. Similar with the findings from other studies done in Kenya, prolonged hospital stays and dirty wounds were the risk associated with postsurgical sepsis at the target hospital.
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###### 

Association of corneal opacity and potential risk factors, eye level analysis (n=596)

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk factor                                          Total no\   Eyes with\   Percentage of eyes\   Univariate analysis   Multivariate analysis                                                  
                                                       of eyes     corneal\     with corneal\                                                                                                      
                                                                   opacity      opacity                                                                                                            
  ---------------------------- ----------------------- ----------- ------------ --------------------- --------------------- ----------------------- -------- --------- ------ ----------- -------- -------
  **Sex**                      Male                    188         29           15.4                  1.0                                                              1.0                         

                               Female                  408         44           10.8                  0.6                   0.4--1.2                0.14               0.7    0.3--1.4    0.314    

  **Age**                      \<45\                   197\        12\          6.1\                  1.0\                  1.3--6.3\               0.01\    \<0.001   1.0\   1.3--6.6\   0.008\   0.001
                               45--64\                 325\        43\          13.2\                 2.8\                  2.2--13.7               \<0.01             3.0\   1.9--12.7   0.001    
                               ≥65                     74          18           24.3                  5.5                                                              4.9                         

  **Education**                Illiterate\             549\        71\          12.9\                 1.0\                  0.04--1.1               0.06                                           
                               Non formal or formal\   47\         2\           4.3\                  0.2                                                                                          
                               education\              14          0            0.0                                                                                                                
                               Some formal                                                                                                                                                         

  **Time since trichiasis**\   0--12 months\           495\        54\          10.9\                 1.0\                  1.2--4.9                0.01               1.0\   1.3--5.5    0.007    
  **surgery**                  \>12 months             101         19           18.8                  2.4                                                              2.7                         

  **Epilation prior to**\      Yes                     442         51           11.5                  1.0                                                                                          
  **surgery**                                                                                                                                                                                      

                               No                      154         22           14.3                  1.2                   0.7--2.3                0.54                                           

  **Frequency of epilation**   Once a week or more     223         21           9.4                   1.0                                                    0.24                                  

                               \< Once a week          218         30           13.8                  1.6                   0.8--3.1                0.20                                           

                               Not at all              155         22           14.2                  1.5                   0.7--3.1                0.26                                           

  **Any surgical**\            No\                     511\        54\          10.6\                 1.0\                  1.3--4.7                0.01               1.0\   1.4--5.9    \<0.01   
  **complication**             Yes                     85          19           22.4                  2.5                                                              2.9                         

  **Recurrence of**\           No\                     556\        63\          11.3\                 1.0\                  1.1--6.4                0.03               1.0\   1.0--6.3    0.042    
  **trichiasis**               Yes                     40          10           25.0                  2.7                                                              2.5                         
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
